SOLVENTUM CORPORATION Earnings Per Share (Diluted)
SOLVENTUM CORPORATION (SOLV) reported Earnings Per Share (Diluted) of $0.53 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- SOLVENTUM CORPORATION earnings per share, diluted for the quarter ending 2026-06-30 was $0.53, a 3.92% increase year-over-year.
- SOLVENTUM CORPORATION earnings per share, diluted for the quarter ending 2026-03-31 was $0.07, a 91.03% decline year-over-year.
- SOLVENTUM CORPORATION earnings per share, diluted for the quarter ending 2025-12-31 was $0.36, a 101.72% increase year-over-year.
- SOLVENTUM CORPORATION earnings per share, diluted for the quarter ending 2025-09-30 was $7.22, a 931.43% increase year-over-year.
- SOLVENTUM CORPORATION earnings per share, diluted for fiscal 2025 was $8.88, a 221.74% increase from fiscal 2024.
- SOLVENTUM CORPORATION earnings per share, diluted for fiscal 2024 was $2.76, a 64.57% decline from fiscal 2023.
- SOLVENTUM CORPORATION earnings per share, diluted for fiscal 2023 was $7.79, a 0.13% increase from fiscal 2022.
- SOLVENTUM CORPORATION earnings per share, diluted for fiscal 2022 was $7.78.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.53 10-Q · filed 2026-08-05 | $0.60 10-Q · filed 2026-08-05 | $0.96 derived: net income ÷ weighted average shares · filed 2026-08-05 | $8.19 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | $0.07 10-Q · filed 2026-05-05 | $0.43 derived: net income ÷ weighted average shares · filed 2026-05-05 | $7.64 derived: net income ÷ weighted average shares · filed 2026-05-05 | $8.16 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | $0.36 derived: net income ÷ weighted average shares · filed 2026-02-27 | $7.57 derived: net income ÷ weighted average shares · filed 2026-02-27 | $8.09 derived: net income ÷ weighted average shares · filed 2026-08-05 | $8.88 10-K · filed 2026-02-27 |
| 2025-09-30 | $7.22 10-Q · filed 2025-11-06 | $7.74 derived: net income ÷ weighted average shares · filed 2026-08-05 | $8.53 10-Q · filed 2025-11-06 | $8.71 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | $0.51 10-Q · filed 2026-08-05 | $1.30 10-Q · filed 2026-08-05 | $1.48 derived: net income ÷ weighted average shares · filed 2026-08-05 | $2.18 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | $0.78 10-Q · filed 2026-05-05 | $0.96 derived: net income ÷ weighted average shares · filed 2026-05-05 | $1.66 derived: net income ÷ weighted average shares · filed 2026-05-05 | $2.18 derived: net income ÷ weighted average shares · filed 2026-05-05 |
| 2024-12-31 | $0.18 derived: net income ÷ weighted average shares · filed 2026-02-27 | $0.88 derived: net income ÷ weighted average shares · filed 2026-02-27 | $1.39 derived: net income ÷ weighted average shares · filed 2026-02-27 | $2.76 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.70 10-Q · filed 2025-11-06 | $1.21 derived: net income ÷ weighted average shares · filed 2025-11-06 | $2.58 10-Q · filed 2025-11-06 | $4.16 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-06-30 | $0.51 10-Q · filed 2025-08-08 | $1.88 10-Q · filed 2025-08-08 | $3.46 derived: net income ÷ weighted average shares · filed 2026-02-27 | $6.12 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2024-03-31 | $1.37 10-Q · filed 2025-05-09 | $2.95 derived: net income ÷ weighted average shares · filed 2026-02-27 | $5.61 derived: net income ÷ weighted average shares · filed 2026-02-27 | $7.47 derived: net income ÷ weighted average shares · filed 2026-02-27 |
| 2023-12-31 | $1.57 derived: net income ÷ weighted average shares · filed 2026-02-27 | $4.24 derived: net income ÷ weighted average shares · filed 2026-02-27 | $6.10 derived: net income ÷ weighted average shares · filed 2026-02-27 | $7.79 10-K · filed 2026-02-27 |
| 2023-09-30 | $2.66 10-Q · filed 2024-11-08 | $4.52 derived: net income ÷ weighted average shares · filed 2024-11-08 | $6.22 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $1.86 10-Q · filed 2024-08-09 | $3.56 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $1.70 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | $7.78 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |